» Articles » PMID: 38402312

Comparison of Cas12a and Cas9-mediated Mutagenesis in Tomato Cells

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 24
PMID 38402312
Authors
Affiliations
Soon will be listed here.
Abstract

Cas12a is a promising addition to the CRISPR toolbox, offering versatility due to its TTTV-protospacer adjacent motif (PAM) and the fact that it induces double-stranded breaks (DSBs) with single-stranded overhangs. We characterized Cas12a-mediated genome editing in tomato using high-throughput amplicon sequencing on protoplasts. Of the three tested variants, Lachnospiraceae (Lb) Cas12a was the most efficient. Additionally, we developed an easy and effective Golden-Gate-based system for crRNA cloning. We compared LbCas12a to SpCas9 by investigating on-target efficacy and specificity at 35 overlapping target sites and 57 (LbCas12a) or 100 (SpCas9) predicted off-target sites. We found LbCas12a an efficient, robust addition to SpCas9, with similar overall though target-dependent efficiencies. LbCas12a induced more and larger deletions than SpCas9, which can be advantageous for specific genome editing applications. Off-target activity for LbCas12a was found at 10 out of 57 investigated sites. One or two mismatches were present distal from the PAM in all cases. We conclude that Cas12a-mediated genome editing is generally precise as long as such off-target sites can be avoided. In conclusion, we have determined the mutation pattern and efficacy of Cas12a-mediated CRISPR mutagenesis in tomato and developed a cloning system for the routine application of Cas12a for tomato genome editing.

Citing Articles

CRISPR/Cas12a-based genome editing for cyanophage of sp.

Yuan S, Li Y, Kou C, Sun Y, Ma Y Synth Syst Biotechnol. 2024; 10(1):140-147.

PMID: 39493338 PMC: 11530783. DOI: 10.1016/j.synbio.2024.09.011.


CRISPR-Cas9/Cas12a systems for efficient genome editing and large genomic fragment deletions in .

Yuan G, Deng S, Czajka J, Dai Z, Hofstad B, Kim J Front Bioeng Biotechnol. 2024; 12:1452496.

PMID: 39479294 PMC: 11521959. DOI: 10.3389/fbioe.2024.1452496.


Next-generation CRISPR technology for genome, epigenome and mitochondrial editing.

Lau C, Liang Q, Zhu H Transgenic Res. 2024; 33(5):323-357.

PMID: 39158822 DOI: 10.1007/s11248-024-00404-x.

References
1.
Shou J, Li J, Liu Y, Wu Q . Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion. Mol Cell. 2018; 71(4):498-509.e4. DOI: 10.1016/j.molcel.2018.06.021. View

2.
Kleinstiver B, Tsai S, Prew M, Nguyen N, Welch M, Lopez J . Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol. 2016; 34(8):869-74. PMC: 4980201. DOI: 10.1038/nbt.3620. View

3.
Shi X, Shou J, Mehryar M, Li J, Wang L, Zhang M . Cas9 has no exonuclease activity resulting in staggered cleavage with overhangs and predictable di- and tri-nucleotide CRISPR insertions without template donor. Cell Discov. 2019; 5:53. PMC: 6796948. DOI: 10.1038/s41421-019-0120-z. View

4.
LeBlanc C, Zhang F, Mendez J, Lozano Y, Chatpar K, Irish V . Increased efficiency of targeted mutagenesis by CRISPR/Cas9 in plants using heat stress. Plant J. 2017; 93(2):377-386. DOI: 10.1111/tpj.13782. View

5.
Hur J, Kim K, Been K, Baek G, Ye S, Hur J . Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat Biotechnol. 2016; 34(8):807-8. DOI: 10.1038/nbt.3596. View